Selected Start-Ups (6/02)
Executive SummaryIn Vivo briefly summarizes the technologies of these recently founded companies: Avera Pharmaceuticals Inc., Celeres Pharmaceuticals Inc., Cell Therapeutics Scandinavia AB, EndoBionics Inc., Tercica Medica Inc. and Vector Rx Inc.
You may also be interested in...
The Novo Nordisk Foundation is sponsoring a panel at Davos this week on finding solutions to the global crisis on antimicrobial resistance – and hopes world leaders will listen.
Neuroscience could be this decade’s big growth story, but clinical and market access challenges differ to oncology.
The US Court of Appeals for the Federal Circuit has upheld a series of inter partes review decisions from 2017 in which three Humira patents were found invalid by the Patent Trial and Appeal Board within the US Patent and Trademark Office.